Literature DB >> 12052097

A fair innings for NICE?

Nick Freemantle1, Karen Bloor, Joanne Eastaugh.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12052097     DOI： 10.2165/00019053-200220060-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

Review 1.  Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

Authors:  N Freemantle
Journal:  BMJ       Date:  2001-04-21

Review 2.  Intergenerational equity: an exploration of the 'fair innings' argument.

Authors:  A Williams
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

3.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

Review 4.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  4 in total
  3 in total

1.  A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?

Authors:  Suzanne Hill; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Rescuing patients from the rule of efficiency: a need to debate the 'rule of rescue'.

Authors:  Sophia Kessabi; Richard de Abreu Lourenco; Michael Wonder
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Challenges for the National Institute for Clinical Excellence.

Authors:  Alan Maynard; Karen Bloor; Nick Freemantle
Journal:  BMJ       Date:  2004-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.